/PRNewswire/ BIOCAPTIVA Ltd ("BIOCAPTIVA"), a company developing the BioCaptis – a revolutionary cell-free DNA (cfDNA) capture device designed to transform.
A University of Edinburgh spin-out that says it is pioneering technology to “transform” liquid biopsy testing in cancer-management has announced an oversubscribed £2.1 million additional seed funding round led by Archangels.
Deal financing led by existing investor, Archangels, with participation from Scottish Enterprise, Cancer Research Horizons and new investor Old College Capital, the University of Edinburgh's
Saliva-based Covid-19 test is less intrusive and cheaper than PCR theiet.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theiet.org Daily Mail and Mail on Sunday newspapers.